登录
注册
Toggle navigation
首页
关于学会
学会动态
翊统
关于我们
三方协调委员会
指导原则
学术年会
培训
翊统学术沙龙
关于《翊统学术沙龙》
历次沙龙活动
年度沙龙
沙龙通知及报名
分会
医院统计分会
青年委员会
OpenChecks
会员管理
站内搜索
搜索
指导原则
学术年会
培训
您当前的位置:
首页
翊统
三方协调委员会
指导原则
Draft
征求意见稿
Draft
试行稿
Final
17
2023.03
Guidance on the Design and Protocol Development of Real-World Studies for Drugs (Draft)
01
2021.11
Guideline on Integrated Summary of Efficacy for Clinical Trials (Draft)
25
2021.04
Guideline on Enrichment Strategies and Designs in Clinical Trials (Draft)
01
2020.11
Guideline on Adaptive Designs for Clinical Trials(Draft)
01
2020.11
Guideline on Non-inferiority Clinical Trials (Draft)
01
2020.11
Guideline on Clinical Trial Data Monitoring Committees(Draft)
01
2020.11
Guideline on the Submission of Clinical Trial Data (Draft )
01
2020.11
Key Considerations in Using Real-World Evidence to Support Drug Development (Draft)
01
2020.11
Guidance on Using Real-World Data to Generate Real-World Evidence (Draft)